NUSIRT SCIENCES INC has a total of 116 patent applications. It decreased the IP activity by 56.0%. Its first patent ever was published in 2012. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, foods and drinks and environmental technology are NEW CHAPTER INC, SHIAO SHIN-JEN and MEDDAY PHARMACEUTICALS.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 30 | |
#2 | WIPO (World Intellectual Property Organization) | 12 | |
#3 | Australia | 11 | |
#4 | EPO (European Patent Office) | 10 | |
#5 | China | 8 | |
#6 | Canada | 7 | |
#7 | South Africa | 7 | |
#8 | Hong Kong | 6 | |
#9 | Israel | 4 | |
#10 | Republic of Korea | 4 | |
#11 | Mexico | 4 | |
#12 | Singapore | 4 | |
#13 | Brazil | 3 | |
#14 | Japan | 3 | |
#15 | Philippines | 3 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Environmental technology | |
#4 | Measurement | |
#5 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Special foods | |
#4 | Foods | |
#5 | Fodder | |
#6 | Climate change mitigation in goods production | |
#7 | Special bacteria in foodstuffs | |
#8 | Heterocyclic compounds | |
#9 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Zemel Michael | 100 |
#2 | Bruckbauer Antje | 90 |
#3 | Baggett Brooke | 24 |
#4 | Grindstaff Ii E Douglas | 21 |
#5 | Michael Zemel | 11 |
#6 | Antje Bruckbauer | 9 |
#7 | Grindstaff E Douglas Ii | 7 |
#8 | E Douglas Grindstaff Ii | 3 |
#9 | Banerjee Jheelam | 2 |
#10 | Bagget Brooke | 1 |
Publication | Filing date | Title |
---|---|---|
WO2019161211A2 | Compositions and methods for the reduction or prevention of hepatic steatosis and nash | |
US2018105498A1 | Compositions and methods for treating metabolic disorders | |
WO2018045335A1 | Nitrogen oxide donors and uses thereof | |
WO2017040407A1 | Compositions and methods for the reduction or prevention of non-alcoholic steatohepatitis (nash) | |
EP3197437A1 | Compositions, methods and kits for treatment of diabetes and/or hyperlipidemia | |
WO2015131152A1 | Compositions and methods for the reduction or prevention of hepatic steatosis | |
BR112015023310A2 | lipid lowering compositions, methods and kits | |
AU2014238157A1 | Compositions, methods, and kits for treatment of pets | |
AU2014238377A1 | Treatment of pets with sirtuin activators | |
CN105101958A | Treating pulmonary conditions | |
CN108452311A | Composition for enhancing energetic supersession and method | |
US2013237605A1 | Compositions, methods, and kits for regulating energy metabolism | |
CN103889411A | Compositions and methods for modulating metabolic pathways |